東北大学

東北大学大学院医学系研究科
腎・膠原病・内分泌内科学分野
東北大学病院 腎・高血圧・内分泌科

論文・著書

～歴史ある論文・著書～

2020年

論文【英文】

  1. Tezuka Y, Turcu AF. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism. Endocr Pract. 2020 Dec;26(12):1416-1424. doi: 10.4158/EP-2020-0277.
  2. Fukushi T, Yamamoto T, Yoshida M, Fujikura E, Miyazaki M, Nakayama M. Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis. Sci Rep. 2020 Dec 10;10(1):21747. doi: 10.1038/s41598-020-78742-z.
  3. Oikawa Y, Izumi R, Koide M, Hagiwara Y, Kanzaki M, Suzuki N, Kikuchi K, Matsuhashi T, Akiyama Y, Ichijo M, Watanabe S, Toyohara T, Suzuki T, Mishima E, Akiyama Y, Ogata Y, Suzuki C, Hayashi H, Kodama EN, Hayashi KI, Itoi E, Aoki M, Kure S, Abe T. Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5. PLoS One. 2020 Dec 2;15(12):e0231064. doi: 10.1371/journal.pone.0231064. eCollection 2020.
  4. Gao X, Yamazaki Y, Pecori A, Tezuka Y, Ono Y, Omata K, Morimoto R, Nakamura Y, Satoh F, Sasano H. Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma. Front Endocrinol (Lausanne). 2020 Nov 10;11:587779. doi: 10.3389/fendo.2020.587779. eCollection 2020.
  5. Ito S, Kashihara N, Shikata K, Nangaku M, Wada T, Okuda Y, Sawanobori T. Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2020 Dec 7;15(12):1715-1727. doi: 10.2215/CJN.06870520. Epub 2020 Nov 25.
  6. Ishida T, Inoue T, Niizuma K, Konno N, Suzuki C, Inoue T, Ezura M, Uenohara H, Abe T, Tominaga T. Prediction of Functional Outcome in Patients with Acute Stroke by Measuring tRNA Derivatives. Cerebrovasc Dis. 2020;49(6):639-646. doi: 10.1159/000511627. Epub 2020 Nov 18.
  7. Yamazaki Y, Gao X, Pecori A, Nakamura Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Satoh F, Sasano H. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients. Front Endocrinol (Lausanne). 2020 Oct 27;11:587769. doi: 10.3389/fendo.2020.587769. eCollection 2020.
  8. Kamata Y, Sato H, Sugiura A, Miyata M, Kisu K, Azuma A. A Case Demonstrating the Pathological Relationship between Granulomatous Vasculitis and Glomerular Lesion in Renal Sarcoidosis. Case Rep Nephrol Dial. 2020 Oct 12;10(3):109-116. doi: 10.1159/000509590. eCollection 2020 Sep-Dec.
  9. Gao X, Yamazaki Y, Tezuka Y, Pieroni J, Ishii K, Atsumi N, Ono Y, Omata K, Morimoto R, Nakamura Y, Satoh F, Sasano H. Intratumoral heterogeneity of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas; ∼An association among morphometry, genotype and cellular senescence∼. J Steroid Biochem Mol Biol. 2020 Nov;204:105764. doi: 10.1016/j.jsbmb.2020.105764. Epub 2020 Sep 28.
  10. Mishima E, Ichijo M, Kawabe T, Kikuchi K, Akiyama Y, Toyohara T, Suzuki T, Suzuki C, Asao A, Ishii N, Fukuda S, Abe T. Germ-Free Conditions Modulate Host Purine Metabolism, Exacerbating Adenine-Induced Kidney Damage. Toxins (Basel). 2020 Aug 26;12(9):547. doi: 10.3390/toxins12090547.
  11. Nanba K, Yamazaki Y, Bick N, Onodera K, Tezuka Y, Omata K, Ono Y, Blinder AR, Tomlins SA, Rainey WE, Satoh F, Sasano H. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients. J Clin Endocrinol Metab. 2020 Nov 1;105(11):e4066-73. doi: 10.1210/clinem/dgaa595.
  12. Shirai H, Sato E, Sekimoto A, Uchida T, Oe Y, Ito S, Sato H, Takahashi N. The effect of aldosterone on adiposity - The role of glucose absorption in the small intestine. Biochem Biophys Res Commun. 2020 Oct 22;531(4):628-635. doi: 10.1016/j.bbrc.2020.07.119. Epub 2020 Aug 17.
  13. Yamakage S, Oe Y, Sekimoto A, Obata H, Yasuta M, Sato E, Kumakura S, Sato H, Sugawara J, Ito S, Takahashi N. Protease-activated receptor 2 contributes to placental development and fetal growth in mice. Thromb Res. 2020 Sep;193:173-179. doi: 10.1016/j.thromres.2020.06.039. Epub 2020 Jul 2.
  14. Yamamoto T, Nakayama M, Miyazaki M, Sato H, Matsushima M, Sato T, Ito S. Impact of lower body mass index on risk of all-cause mortality and infection-related death in Japanese chronic kidney disease patients. BMC Nephrol. 2020 Jun 30;21(1):244. doi: 10.1186/s12882-020-01894-7.
  15. Yokoyama H, Yamamoto R, Imai E, Maruyama S, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Furuichi K, Fujimoto K, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020 Oct;24(10):893-909. doi: 10.1007/s10157-020-01913-9. Epub 2020 Jun 19.
  16. Mishima E, Anzai N, Miyazaki M, Abe T. Uric Acid Elevation by Favipiravir, an Antiviral Drug. Tohoku J Exp Med. 2020 Jun;251(2):87-90. doi: 10.1620/tjem.251.87.
  17. Rashad S, Han X, Sato K, Mishima E, Abe T, Tominaga T, Niizuma K. The stress specific impact of ALKBH1 on tRNA cleavage and tiRNA generation. RNA Biol. 2020 Aug;17(8):1092-1103. doi: 10.1080/15476286.2020.1779492. Epub 2020 Jun 21.
  18. Akiu M, Yamamoto T, Fujikura E, Okamoto K, Nakagawa A, Yoshida M, Nakamichi T, Fukushi T, Nagasawa T, Oe Y, Nakayama M, Sato H, Tominaga T, Ito S, Harigae H, Miyazaki M. Questionnaire survey on the prescription of renal replacement therapy for acute phase patients on maintenance dialysis who developed cerebrovascular disease. Clin Exp Nephrol. 2020 Sep;24(9):821-828. doi: 10.1007/s10157-020-01905-9. Epub 2020 May 25.
  19. Sato E, Tsunokuni Y, Kaneko M, Saigusa D, Saito R, Shimma S, Sekimoto A, Kawana Y, Oe Y, Ito S, Sato H, Takahashi N. Metabolomics of a mouse model of preeclampsia induced by overexpressing soluble fms-like tyrosine kinase 1. Biochem Biophys Res Commun. 2020 Jul 5;527(4):1064-1071. doi: 10.1016/j.bbrc.2020.04.079. Epub 2020 May 21.
  20. Iwasaki T, Mishima E, Suzuki T, Kikuchi K, Toyohara T, Seiji K, Takase K, Miyazaki M, Harigae H, Ito S, Abe T. Kidney enlargement effect of angioplasty for nonatherosclerotic renovascular disease: reversibility of ischemic kidney. Hypertens Res. 2020 Nov;43(11):1214-1221. doi: 10.1038/s41440-020-0473-6. Epub 2020 May 22.
  21. Watanabe H, Takeuchi Y, Taniuchi S, Sato H, Nakamura Y, Sasano H, Joh K. Polyclonal immunoglobulin G deposition on the tubular basement membrane in a diabetic nephropathy: A case report. Pathol Int. 2020 Jul;70(7):463-469. doi: 10.1111/pin.12940. Epub 2020 May 17.
  22. Gao X, Yamazaki Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Nakamura Y, Satoh F, Sasano H. The Effect of Extracellular Calcium Metabolism on Aldosterone Biosynthesis in Physiological and Pathological Status. Horm Metab Res. 2020 Jun;52(6):448-453. doi: 10.1055/a-1157-0511. Epub 2020 May 13.
  23. Tanaka T, Satoh F, Ujihara M, Midorikawa S, Kaneko T, Takeda T, Suzuki A, Sato M, Shimatsu A. A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease. Endocr J. 2020 Aug 28;67(8):841-852. doi: 10.1507/endocrj.EJ19-0617. Epub 2020 May 1.
  24. Yamakoshi S, Ito O, Rong R, Ohsaki Y, Nakamura T, Hirose T, Takahashi K, Mori T, Totsune K, Kohzuki M. High Salt Intake-Increased (Pro)renin Receptor Expression Is Exaggerated in the Kidney of Dahl Salt-Sensitive Rats. Hypertension. 2020 Jun;75(6):1447-1454. doi: 10.1161/HYPERTENSIONAHA.119.13905. Epub 2020 Apr 27.
  25. Abe M, Akaishi T, Shoji M, Yamaguchi T, Miki T, Satoh F, Takayama S, Yamasaki S, Kawaguchi K, Sato H, Ishii T, Ito S; CKOALA study group. Reno-protective effects of oral alkalizing agents in chronic kidney disease with aciduria: protocol for a randomized cohort study. BMC Nephrol. 2020 Apr 22;21(1):144. doi: 10.1186/s12882-020-01807-8.
  26. Kawaguchi T, Nagasawsa T, Tsuruya K, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Ubara Y; Committee of Practical Guide for Kidney Biopsy 2019. Correction to: A nationwide survey on clinical practice patterns and bleeding complications of percutaneous native kidney biopsy in Japan. Clin Exp Nephrol. 2020 May;24(5):402-403. doi: 10.1007/s10157-020-01883-y.
  27. Mitsui S, Oe Y, Sekimoto A, Sato E, Hashizume Y, Yamakage S, Kumakura S, Sato H, Ito S, Takahashi N. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease. Am J Physiol Renal Physiol. 2020 May 1;318(5):F1067-F1073. doi: 10.1152/ajprenal.00595.2019. Epub 2020 Mar 23.
  28. Kawaguchi T, Nagasawsa T, Tsuruya K, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Ubara Y; Committee of Practical Guide for Kidney Biopsy 2019. A nationwide survey on clinical practice patterns and bleeding complications of percutaneous native kidney biopsy in Japan. Clin Exp Nephrol. 2020 May;24(5):389-401. doi: 10.1007/s10157-020-01869-w. Epub 2020 Mar 18.
  29. Kumakura S, Okamoto K, Takeuchi S, Yoshida M, Nakamichi T, Nagasawa T, Fujikura E, Yamamoto T, Saito M, Hanita T, Satoh M, Sato H, Ito S, Harigae H, Miyazaki M. Kidney function, blood pressure and proteinuria were associated with pregnancy outcomes of pregnant women with chronic kidney disease: a single-center, retrospective study in the Asian population. Clin Exp Nephrol. 2020 Jun;24(6):547-556. doi: 10.1007/s10157-020-01865-0. Epub 2020 Mar 11.
  30. Sato E, Hosomi K, Sekimoto A, Mishima E, Oe Y, Saigusa D, Ito S, Abe T, Sato H, Kunisawa J, Niwa T, Takahashi N. Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition. Biochem Biophys Res Commun. 2020 May 7;525(3):773-779. doi: 10.1016/j.bbrc.2020.02.141. Epub 2020 Mar 5.
  31. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020 Jun;24(6):526-540. doi: 10.1007/s10157-020-01864-1. Epub 2020 Mar 7.
  32. Mishima E, Mori T, Nakajima Y, Toyohara T, Kikuchi K, Oikawa Y, Matsuhashi T, Maeda Y, Suzuki T, Kudo M, Ito S, Sohara E, Uchida S, Abe T. HPRT-related hyperuricemia with a novel p.V35M mutation in HPRT1 presenting familial juvenile gout. CEN Case Rep. 2020 Aug;9(3):210-214. doi: 10.1007/s13730-020-00459-9. Epub 2020 Mar 3.
  33. Tezuka Y, Yamazaki Y, Ono Y, Morimoto R, Omata K, Seiji K, Takase K, Kawasaki Y, Ito A, Nakamura Y, Harigae H, Sasano H, Satoh F. Unique Sex Steroid Profiles in Estrogen-Producing Adrenocortical Adenoma Associated With Bilateral Hyperaldosteronism. J Endocr Soc. 2020 Jan 23;4(2):bvaa004. doi: 10.1210/jendso/bvaa004. eCollection 2020 Feb 1.
  34. Misawa K, Hasegawa T, Mishima E, Jutabha P, Ouchi M, Kojima K, Kawai Y, Matsuo M, Anzai N, Nagasaki M. Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels. Genetics. 2020 Apr;214(4):1079-1090. doi: 10.1534/genetics.119.303006. Epub 2020 Jan 31.
  35. Mishima E, Suzuki T, Ito S. Selection of Patients for Angioplasty for Treatment of Atherosclerotic Renovascular Disease: Predicting Responsive Patients. Am J Hypertens. 2020 Apr 29;33(5):391-401. doi: 10.1093/ajh/hpaa016.
  36. Mishima E, Ota H, Suzuki T, Toyohara T, Seiji K, Ito S, Saiki Y, Takase K, Abe T. Apparent Diffusion Coefficient in the Resolution of Renal Ischemia after Angioplasty on Diffusion-weighted Imaging: Renal Artery Stenosis Caused by Progressive Thrombosis in Residual Chronic Aortic Dissection. Intern Med. 2020 May 1;59(9):1173-1177. doi: 10.2169/internalmedicine.3855-19. Epub 2020 Jan 17.
  37. Oe Y, Sato E, Sato H, Miyazaki M, Ito S, Takahashi N. Uremic toxins alter coagulation and fibrinolysis-related genes expression in human endothelial cells. Thromb Res. 2020 Feb;186:75-77. doi: 10.1016/j.thromres.2019.12.017. Epub 2019 Dec 26.
  38. Suzuki S, Yokoyama A, Noro E, Aoki S, Shimizu K, Shimada H, Sugawara A. Expression and pathophysiological significance of carbohydrate response element binding protein (ChREBP) in the renal tubules of diabetic kidney. Endocr J. 2020 Mar 28;67(3):335-345. doi: 10.1507/endocrj.EJ19-0133. Epub 2019 Dec 7.
  39. Ono Y, Yamazaki Y, Omata K, Else T, Tomlins SA, Rhayem Y, Williams TA, Reincke M, Carling T, Monticone S, Mulatero P, Beuschlein F, Ito S, Satoh F, Rainey WE, Sasano H. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e282-9. doi: 10.1210/clinem/dgz235.
  40. Ito S, Itoh H, Rakugi H, Okuda Y, Yoshimura M, Yamakawa S. Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study). Hypertension. 2020 Jan;75(1):51-58. doi: 10.1161/HYPERTENSIONAHA.119.13569. Epub 2019 Dec 2.
  41. Mishima E, Sato E, Ito J, Yamada KI, Suzuki C, Oikawa Y, Matsuhashi T, Kikuchi K, Toyohara T, Suzuki T, Ito S, Nakagawa K, Abe T. Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers. J Am Soc Nephrol. 2020 Feb;31(2):280-296. doi: 10.1681/ASN.2019060570. Epub 2019 Nov 25.
  42. Sekimoto A, Tanaka K, Hashizume Y, Sato E, Sato H, Ikeda T, Takahashi N. Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice. Biochem Biophys Res Commun. 2020 Jan 15;521(3):769-774. doi: 10.1016/j.bbrc.2019.10.186. Epub 2019 Nov 6.
  43. Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultzekool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller P, Yang J, Nian Chee NY, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Chang CC, Wu VC, Somloova Z, Maiolino G, Barbiero G, Battistel M, Lenzini L, Quaia E, Pessina AC, Rossi GP. Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization. J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgz017. doi: 10.1210/clinem/dgz017.
  44. Nanto-Hara F, Kanemitsu Y, Fukuda S, Kikuchi K, Asaji K, Saigusa D, Iwasaki T, Ho HJ, Mishima E, Suzuki T, Suzuki C, Tsukimi T, Matsuhashi T, Oikawa Y, Akiyama Y, Kure S, Owada Y, Tomioka Y, Soga T, Ito S, Abe T. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease. Nephrol Dial Transplant. 2020 Feb 1;35(2):250-264. doi: 10.1093/ndt/gfz126.
TOP